Tacrolimus(TAC) In The Treatment Of Birdshot Retinochoroidopathy(BRC): Safety Profile and Efficacy
Farrah Islam(Dar Al-Shifa Hospital), Graham E. Holder(Moorfields Eye Hospital), Anthony G. Robson(Moorfields Eye Hospital NHS Foundation Trust), Angela Rees(Moorfields Eye Hospital NHS Foundation Trust), Chysoula Koutsiouki(Moorfields Eye Hospital), Mark Westcott(Barts Health NHS Trust), Luke Nicholson(Moorfields Eye Hospital NHS Foundation Trust), Carlos Pavésio(Moorfields Eye Hospital NHS Foundation Trust)
UCL Discovery (University College London)
September 26, 2016
Cited by 1
Related Papers
Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production
|Lara D. Veeken|2008|149
British Ocular Syphilis Study (BOSS): 2-Year National Surveillance Study of Intraocular Inflammation Secondary to Ocular Syphilis
|Investigative Ophthalmology & Visual Science|2014|138
Viral posterior uveitis
|Survey of Ophthalmology|2016|126
Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysis
|Survey of Ophthalmology|2016|110
COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs
|British Journal of Ophthalmology|2020|106